Biopharmaceutical cold chain best practices
Lisa Harrington, President, lharrington group LLC |
<p>Ensuring product integrity and security throughout the supply chain has always been a top priority for biopharmaceutical manufacturers. However, a convergence of new forces — intense cost pressure and competition, a changing product portfolio, stricter regulations, rapid growth in emerging markets, and increasing risk — is raising the stakes significantly.</p>
Cool Cargo NewsLogistics Technology News